{"id":"https://openalex.org/W2460120137","doi":null,"title":"[The rise in fluoroquinolone-resistant Neisseria gonorrhoeae among people attending the Municipal Health Service's clinic for sexually transmitted diseases in Amsterdam, the Netherlands; cefotaxime now first-choice treatment for uncomplicated gonorrhoea].","display_name":"[The rise in fluoroquinolone-resistant Neisseria gonorrhoeae among people attending the Municipal Health Service's clinic for sexually transmitted diseases in Amsterdam, the Netherlands; cefotaxime now first-choice treatment for uncomplicated gonorrhoea].","publication_year":2004,"publication_date":"2004-10-23","ids":{"openalex":"https://openalex.org/W2460120137","mag":"2460120137","pmid":"https://pubmed.ncbi.nlm.nih.gov/15553358"},"language":"nl","primary_location":{"id":"pmid:15553358","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15553358","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nederlands tijdschrift voor geneeskunde","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://hdl.handle.net/11370/2f4cd42e-404b-40f7-a8ec-dd4e316f9e26","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5053030797","display_name":"Marion E Kolader","orcid":"https://orcid.org/0000-0001-8273-4128","observed_orcids":["https://orcid.org/0000-0001-8273-4128"]},"institutions":[{"id":"https://openalex.org/I4210148356","display_name":"GGD Amsterdam","ror":"https://ror.org/04gbbq803","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210088893","https://openalex.org/I4210148356"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"M Kolader","raw_affiliation_strings":["GG&GD, Nieuwe Achtergracht 100, 1018 WT Amsterdam"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GG&GD, Nieuwe Achtergracht 100, 1018 WT Amsterdam","institution_ids":["https://openalex.org/I4210148356"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073690278","display_name":"Paul G. H. Peerbooms","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P G H Peerbooms","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105529888","display_name":"Pieter C. van Voorst Vader","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P C van Voorst Vader","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091090642","display_name":"Jan E A M van Bergen","orcid":"https://orcid.org/0000-0003-3245-1693","observed_orcids":["https://orcid.org/0000-0003-3245-1693"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J E A M van Bergen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110230233","display_name":"J S A Fennema","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J S A Fennema","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5066471533","display_name":"Henry J.C. de Vries","orcid":"https://orcid.org/0000-0001-9784-547X","observed_orcids":["https://orcid.org/0000-0001-9784-547X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H J C de Vries","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.9425,"has_fulltext":true,"cited_by_count":9,"citation_normalized_percentile":{"value":0.70955081,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"148","issue":"43","first_page":"2129","last_page":"32"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10428","display_name":"Reproductive tract infections research","score":0.948199987411499,"subfield":{"id":"https://openalex.org/subfields/2404","display_name":"Microbiology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10428","display_name":"Reproductive tract infections research","score":0.948199987411499,"subfield":{"id":"https://openalex.org/subfields/2404","display_name":"Microbiology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.029500000178813934,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10873","display_name":"Bacterial Infections and Vaccines","score":0.005100000184029341,"subfield":{"id":"https://openalex.org/subfields/2404","display_name":"Microbiology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neisseria-gonorrhoeae","display_name":"Neisseria gonorrhoeae","score":0.9449999928474426},{"id":"https://openalex.org/keywords/gonorrhea","display_name":"gonorrhea","score":0.9259999990463257},{"id":"https://openalex.org/keywords/fluoroquinolone-resistance","display_name":"fluoroquinolone resistance","score":0.9900000095367432},{"id":"https://openalex.org/keywords/cefotaxime","display_name":"cefotaxime","score":0.8360000252723694},{"id":"https://openalex.org/keywords/antimicrobial-susceptibility","display_name":"antimicrobial susceptibility","score":0.6909999847412109},{"id":"https://openalex.org/keywords/sexually-transmitted-infections","display_name":"sexually transmitted infections","score":0.703000009059906},{"id":"https://openalex.org/keywords/men-who-have-sex-with-men","display_name":"men who have sex with men","score":0.9929999709129333},{"id":"https://openalex.org/keywords/ciprofloxacin","display_name":"ciprofloxacin","score":0.7429999709129333},{"id":"https://openalex.org/keywords/beta-lactamase","display_name":"beta-lactamase","score":0.7409999966621399}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9229148030281067},{"id":"https://openalex.org/C2779166590","wikidata":"https://www.wikidata.org/wiki/Q131129","display_name":"Neisseria gonorrhoeae","level":2,"score":0.9088884592056274},{"id":"https://openalex.org/C2778512257","wikidata":"https://www.wikidata.org/wiki/Q256602","display_name":"Ciprofloxacin","level":3,"score":0.6260377764701843},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.5568119287490845},{"id":"https://openalex.org/C2778082588","wikidata":"https://www.wikidata.org/wiki/Q101896","display_name":"Gonorrhea","level":3,"score":0.5484354496002197},{"id":"https://openalex.org/C2778719061","wikidata":"https://www.wikidata.org/wiki/Q417968","display_name":"Cefotaxime","level":3,"score":0.5280084609985352},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.4948360323905945},{"id":"https://openalex.org/C2778907293","wikidata":"https://www.wikidata.org/wiki/Q165399","display_name":"Azithromycin","level":3,"score":0.483294278383255},{"id":"https://openalex.org/C2776939746","wikidata":"https://www.wikidata.org/wiki/Q853451","display_name":"Men who have sex with men","level":4,"score":0.46439486742019653},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.34100237488746643},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.3348636031150818},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.3206983208656311},{"id":"https://openalex.org/C2776983459","wikidata":"https://www.wikidata.org/wiki/Q41083","display_name":"Syphilis","level":3,"score":0.19993805885314941},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.18577691912651062},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.12154695391654968},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002439","descriptor_name":"Cefotaxime","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006069","descriptor_name":"Gonorrhea","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006069","descriptor_name":"Gonorrhea","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":false},{"descriptor_ui":"D006069","descriptor_name":"Gonorrhea","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008826","descriptor_name":"Microbial Sensitivity Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009344","descriptor_name":"Neisseria gonorrhoeae","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D009426","descriptor_name":"Netherlands","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012725","descriptor_name":"Sexual Behavior","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018451","descriptor_name":"Homosexuality, Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D024841","descriptor_name":"Fluoroquinolones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D024881","descriptor_name":"Drug Resistance, Bacterial","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":6,"locations":[{"id":"pmid:15553358","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15553358","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nederlands tijdschrift voor geneeskunde","raw_type":"Journal Article"},{"id":"pmh:amcpub:oai:pure.amc.nl:publications/43c2164d-2c3d-48a8-9bda-0480bdf441bd","doi":null,"is_oa":false,"landing_page_url":"https://pure.amc.nl/en/publications/toename-van-fluorochinolonresistentie-bij-neisseria-gonorrhoeae-onder-bezoekers-van-de-soapolikliniek-in-amsterdam-cefotaxim-nu-als-eerste-keus-aanbevolen-voor-ongecompliceerde-gonorroe(43c2164d-2c3d-48a8-9bda-0480bdf441bd).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Nederlands tijdschrift voor geneeskunde, 148(43), 2129 - 2132. Bohn Stafleu van Loghum","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire_cris_publications/8bb06a79-40cb-4637-901e-59870ed05a7d","doi":null,"is_oa":false,"landing_page_url":"https://pure.amsterdamumc.nl/en/publications/8bb06a79-40cb-4637-901e-59870ed05a7d","pdf_url":null,"source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Kolader, M, Peerbooms, P G H, van Voorst Vader, P C, van Bergen, J E A M, Fennema, J S A & de Vries, H J C 2004, 'Toename van fluorochinolonresistentie bij Neisseria gonorrhoeae onder bezoekers van de soa-polikliniek in Amsterdam; cefotaxim nu als eerste keus aanbevolen voor ongecompliceerde gonorroe', Nederlands tijdschrift voor geneeskunde, vol. 148, no. 43, pp. 2129-2132.","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.rug.nl:openaire/2f4cd42e-404b-40f7-a8ec-dd4e316f9e26","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/11370/2f4cd42e-404b-40f7-a8ec-dd4e316f9e26","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Kolader, M, Peerbooms, P G H, van Voorst Vader, P C, Van Bergen, J E A M, Fennema, J S A & De Vries, H J C 2004, 'Toename van fluorochinolonresistentie bij Neisseria gonorrhoeae onder bezoekers van de soa-polikliniek in Amsterdam; cefotaxim nu als eerste keus aanbevolen voor ongecompliceerde gonorroe', Nederlands Tijdschrift voor Geneeskunde, vol. 148, no. 43, pp. 2129-2132.","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:rug:oai:pure.rug.nl:publications/2f4cd42e-404b-40f7-a8ec-dd4e316f9e26","doi":null,"is_oa":false,"landing_page_url":"https://research.rug.nl/en/publications/2f4cd42e-404b-40f7-a8ec-dd4e316f9e26","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Nederlands Tijdschrift voor Geneeskunde, 148(43), 2129 - 2132. NLM (Medline)","raw_type":"info:eu-repo/semantics/article"},{"id":"mag:2460120137","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15553358","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":{"id":"pmh:oai:pure.rug.nl:openaire/2f4cd42e-404b-40f7-a8ec-dd4e316f9e26","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/11370/2f4cd42e-404b-40f7-a8ec-dd4e316f9e26","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Kolader, M, Peerbooms, P G H, van Voorst Vader, P C, Van Bergen, J E A M, Fennema, J S A & De Vries, H J C 2004, 'Toename van fluorochinolonresistentie bij Neisseria gonorrhoeae onder bezoekers van de soa-polikliniek in Amsterdam; cefotaxim nu als eerste keus aanbevolen voor ongecompliceerde gonorroe', Nederlands Tijdschrift voor Geneeskunde, vol. 148, no. 43, pp. 2129-2132.","raw_type":"info:eu-repo/semantics/article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7034708519","https://openalex.org/W4299444225","https://openalex.org/W2095086887","https://openalex.org/W2100183741","https://openalex.org/W2411374708","https://openalex.org/W2087605970","https://openalex.org/W2188095577","https://openalex.org/W2255856315","https://openalex.org/W2074273157","https://openalex.org/W2016489385"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"report":[2],"the":[3,8,18,45,84,219],"incidence":[4,199],"of":[5,10,77,101,200],"gonorrhoea":[6,39,225],"and":[7,53,166,214],"development":[9],"resistance":[11],"to":[12,95,111,136,159,168,209,234],"Neisseria":[13,78],"gonorrhoeae":[14,79],"among":[15,202],"attendees":[16,43],"at":[17,44,83],"Municipal":[19,86],"Health":[20,87],"Service's":[21,88],"STD-clinic":[22,89],"in":[23,63,93,97,109,113,130,134,138,142,157,164,173,183,185],"Amsterdam,":[24],"The":[25,59,75,99,197],"Netherlands,":[26],"2000-2003.":[27],"DESIGN:":[28],"Descriptive.":[29],"METHOD:":[30],"Urethral":[31],"or":[32],"cervical":[33],"swabs":[34,55],"for":[35,37,71,223],"culture":[36],"N.":[38],"were":[40,56,69,181],"taken":[41],"from":[42,91,107,128,152],"STD-clinic.":[46],"Depending":[47],"on":[48],"reported":[49],"sexual":[50],"techniques":[51],"throat":[52],"rectal":[54],"also":[57],"taken.":[58],"disk":[60],"diffusion":[61],"technique":[62],"combination":[64],"with":[65,125,207],"a":[66],"beta-lactamase":[67],"test":[68],"used":[70],"sensitivity":[72],"testing.":[73],"RESULTS.":[74],"number":[76,100],"(NG)":[80],"isolates":[81,105,119,132,140,180],"collected":[82],"Amsterdam":[85],"decreased":[90],"1047":[92],"2002":[94,165],"772":[96],"2003.":[98],"fluoroquinolone-resistant":[102],"NG":[103],"(FRNG)":[104],"rose":[106,151],"3":[108],"2000":[110,135,158],"56":[112],"2003":[114,143,174,186],"(p":[115,144,175],"<":[116,145],"0.001).":[117,146],"FRNG":[118,150,179,201],"amongst":[120],"men":[121,126,203,208],"who":[122,204],"have":[123,205],"sex":[124,206],"increased":[127],"1":[129],"568":[131],"(0.2%)":[133],"50":[137],"478":[139],"(10.5%)":[141],"Amongst":[147],"heterosexual":[148],"men,":[149],"2":[153],"per":[154,161,170],"275":[155],"(0.7%)":[156],"16":[160],"297":[162],"(5.4%)":[163],"dropped":[167],"6":[169],"190":[171],"(3.4%)":[172],"=":[176],"0.146).":[177],"No":[178],"found":[182],"women":[184],"(2000:":[187],"0/180":[188],"(0.0%);":[189],"2001:":[190],"2/160":[191],"(1.3%);":[192],"2002:":[193],"4/183":[194],"(2.2%).":[195],"CONCLUSION:":[196],"recent":[198],"over":[210],"5%":[211],"makes":[212],"ciprofloxacin":[213],"other":[215],"fluoroquinolones":[216],"obsolete":[217],"as":[218],"first-choice":[220],"treatment":[221],"option":[222],"uncomplicated":[224],"if":[226],"no":[227],"antibiogram":[228,239],"is":[229,232,240],"available.":[230],"It":[231],"advised":[233],"use":[235],"cefotaxim":[236],"when":[237],"an":[238],"not":[241],"available":[242],"(yet).":[243]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-07-22T00:00:00"}